This study utilizes the direct conversion of skin-derived fibroblasts into iNs from patients with Spinal Muscular Atrophy (SMA) and IGHMBP2-related disorders (SMARD1/CMT2S). The gene discussed is IGHMBP2; the disease is proximal spinal muscular atrophy.